Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1,800,000 Profiles
- More than 3,500 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Habibe Karacay
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.8 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Procedures
Living Beings
Concepts & Ideas
Disorders
Anatomy
Sign-in to see full Profile
Network (preview)
29
Goldenberg, David
26
Sharkey, Robert
17
McBride, William
16
Hansen, Hans
12
Rossi, Edmund
11
Griffiths, Gary
11
Chang, Chien-Hsing
6
Horak, Ivan
6
Cardillo, Thomas
5
Chang, Chien-Hsing
5
Mattes, Jules
4
McBride, William
4
Rossi, Edmund
4
Losman, Michele
4
Gold, David
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Habibe Karacay (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2010: Sharkey Robert M; Karacay Habibe; Goldenberg David M
Improving the treatment of non-Hodgkin lymphoma with antibody-targeted radionuclides.
Cancer 2010;116(4 Suppl):1134-45.
-
2009: Karacay Habibe; Sharkey Robert M; Gold David V; Ragland Dan R; McBride William J; Rossi Edmund A; Chang Chien-Hsing; Goldenberg David M
Pretargeted radioimmunotherapy of pancreatic cancer xenografts: TF10-90Y-IMP-288 alone and combined with gemcitabine.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(12):2008-16.
-
2009: McBride William J; Sharkey Robert M; Karacay Habibe; D'Souza Christopher A; Rossi Edmund A; Laverman Peter; Chang Chien-Hsing; Boerman Otto C; Goldenberg David M
A novel method of 18F radiolabeling for PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(6):991-8.
-
2009: Sharkey Robert M; Karacay Habibe; Johnson Christine R; Litwin Samuel; Rossi Edmund A; McBride William J; Chang Chien-Hsing; Goldenberg David M
Pretargeted versus directly targeted radioimmunotherapy combined with anti-CD20 antibody consolidation therapy of non-Hodgkin lymphoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(3):444-53.
-
2008: Mattes M Jules; Sharkey Robert M; Karacay Habibe; Czuczman Myron S; Goldenberg David M
Therapy of advanced B-lymphoma xenografts with a combination of 90Y-anti-CD22 IgG (epratuzumab) and unlabeled anti-CD20 IgG (veltuzumab).
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(19):6154-60.
-
2008: Sharkey Robert M; Karacay Habibe; Litwin Samuel; Rossi Edmund A; McBride William J; Chang Chien-Hsing; Goldenberg David M
Improved therapeutic results by pretargeted radioimmunotherapy of non-Hodgkin's lymphoma with a new recombinant, trivalent, anti-CD20, bispecific antibody.
Cancer research 2008;68(13):5282-90.
-
2008: Gold David V; Goldenberg David M; Karacay Habibe; Rossi Edmund A; Chang Chien-Hsing; Cardillo Thomas M; McBride William J; Sharkey Robert M
A novel bispecific, trivalent antibody construct for targeting pancreatic carcinoma.
Cancer research 2008;68(12):4819-26.
-
2008: Sharkey Robert M; Karacay Habibe; Vallabhajosula Shankar; McBride William J; Rossi Edmund A; Chang Chien-Hsing; Goldsmith Stanley J; Goldenberg David M
Metastatic human colonic carcinoma: molecular imaging with pretargeted SPECT and PET in a mouse model.
Radiology 2008;246(2):497-507.
-
2007: Sharkey Robert M; Karacay Habibe; McBride William J; Rossi Edmund A; Chang Chien-Hsing; Goldenberg David M
Bispecific antibody pretargeting of radionuclides for immuno single-photon emission computed tomography and immuno positron emission tomography molecular imaging: an update.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(18 Pt 2):5577s-5585s.
-
2007: Brard Pierre-Yves; Karacay Habibe; Stein Rhona; Sharkey Robert M; Mattes M Jules; Chang Chien-Hsing; Rossi Edmund A; McBride William J; Goldenberg David M
A divalent hapten-peptide induces apoptosis in human non hodgkin lymphoma cell lines targeted by anti-CD20xanti-hapten bispecific antibodies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(18 Pt 2):5564s-5571s.
-
2006: McBride William J; Zanzonico Pat; Sharkey Robert M; Norén Carl; Karacay Habibe; Rossi Edmund A; Losman Michele J; Brard Pierre-Yves; Chang Chien-Hsing; Larson Steven M; Goldenberg David M
Bispecific antibody pretargeting PET (immunoPET) with an 124I-labeled hapten-peptide.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(10):1678-88.
-
2005: Karacay Habibe; Brard Pierre-Yves; Sharkey Robert M; Chang Chien-Hsing; Rossi Edmund A; McBride William J; Ragland Dan R; Horak Ivan D; Goldenberg David M
Therapeutic advantage of pretargeted radioimmunotherapy using a recombinant bispecific antibody in a human colon cancer xenograft.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(21):7879-85.
-
2005: Sharkey Robert M; Cardillo Thomas M; Rossi Edmund A; Chang Chien-Hsing; Karacay Habibe; McBride William J; Hansen Hans J; Horak Ivan D; Goldenberg David M
Signal amplification in molecular imaging by pretargeting a multivalent, bispecific antibody.
Nature medicine 2005;11(11):1250-5.
-
2005: Rossi Edmund A; Chang Chien-Hsing; Losman Michele J; Sharkey Robert M; Karacay Habibe; McBride William; Cardillo Thomas M; Hansen Hans J; Qu Zhengxing; Horak Ivan D; Goldenberg David M
Pretargeting of carcinoembryonic antigen-expressing cancers with a trivalent bispecific fusion protein produced in myeloma cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(19 Pt 2):7122s-7129s.
-
2005: Sharkey Robert M; Karacay Habibe; Cardillo Thomas M; Chang Chien-Hsing; McBride William J; Rossi Edmund A; Horak Ivan D; Goldenberg David M
Improving the delivery of radionuclides for imaging and therapy of cancer using pretargeting methods.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(19 Pt 2):7109s-7121s.
-
2005: Modrak David E; Karacay Habibe; Cardillo Thomas M; Newsome Guy; Goldenberg David M; Gold David V
Identification of a Mu-9 (anti-colon-specific antigen-p)-reactive peptide having homology to CA125 (MUC16).
International journal of oncology 2005;26(6):1591-6.
-
2005: Sharkey R M; Karacay H; Chang C-H; McBride W J; Horak I D; Goldenberg D M
Improved therapy of non-Hodgkin's lymphoma xenografts using radionuclides pretargeted with a new anti-CD20 bispecific antibody.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(6):1064-9.
-
2004: Cardillo Thomas M; Karacay Habibe; Goldenberg David M; Yeldell Dion; Chang Chien-Hsing; Modrak David E; Sharkey Robert M; Gold David V
Improved targeting of pancreatic cancer: experimental studies of a new bispecific antibody, pretargeting enhancement system for immunoscintigraphy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(10):3552-61.
-
2004: Griffiths Gary L; Chang Chien-Hsing; McBride William J; Rossi Edmund A; Sheerin Agatha; Tejada German R; Karacay Habibe; Sharkey Robert M; Horak Ivan D; Hansen Hans J; Goldenberg David M
Reagents and methods for PET using bispecific antibody pretargeting and 68Ga-radiolabeled bivalent hapten-peptide-chelate conjugates.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(1):30-9.
-
2003: Sharkey Robert M; Karacay Habibe; Richel Heidi; McBride William J; Rossi Edmund A; Chang Ken; Yeldell Dion; Griffiths Gary L; Hansen Hans J; Goldenberg David M
Optimizing bispecific antibody pretargeting for use in radioimmunotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 2):3897S-913S.
-
2003: Rossi Edmund A; Sharkey Robert M; McBride William; Karacay Habibe; Zeng Li; Hansen Hans J; Goldenberg David M; Chang Chien-Hsing
Development of new multivalent-bispecific agents for pretargeting tumor localization and therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 2):3886S-96S.
-
2003: Goldenberg David M; Chang Chien-Hsing; Sharkey Robert M; Rossi Edmund A; Karacay Habibe; McBride William; Hansen Hans J; Chatal Jean-Francois; Barbet Jacques
Radioimmunotherapy: is avidin-biotin pretargeting the preferred choice among pretargeting methods?
European journal of nuclear medicine and molecular imaging 2003;30(5):777-80.
-
2003: Sharkey Robert M; McBride William J; Karacay Habibe; Chang Ken; Griffiths Gary L; Hansen Hans J; Goldenberg David M
A universal pretargeting system for cancer detection and therapy using bispecific antibody.
Cancer research 2003;63(2):354-63.
-
2002: Karacay H; Sharkey R M; McBride W J; Griffiths G L; Qu Z; Chang K; Hansen H J; Goldenberg D M
Pretargeting for cancer radioimmunotherapy with bispecific antibodies: role of the bispecific antibody's valency for the tumor target antigen.
Bioconjugate chemistry 2002;13(5):1054-70.
-
2002: Chang Chien-Hsing; Sharkey Robert M; Rossi Edmund A; Karacay Habibe; McBride William; Hansen Hans J; Chatal Jean-François; Barbet Jacques; Goldenberg David M
Molecular advances in pretargeting radioimunotherapy with bispecific antibodies.
Molecular cancer therapeutics 2002;1(7):553-63.
-
2000: Karacay H; McBride W J; Griffiths G L; Sharkey R M; Barbet J; Hansen H J; Goldenberg D M
Experimental pretargeting studies of cancer with a humanized anti-CEA x murine anti-[In-DTPA] bispecific antibody construct and a (99m)Tc-/(188)Re-labeled peptide.
Bioconjugate chemistry 2000;11(6):842-54.
-
1999: Govindan S V; Mattes M J; Stein R; McBride B J; Karacay H; Goldenberg D M; Hansen H J; Griffiths G L
Labeling of monoclonal antibodies with diethylenetriaminepentaacetic acid-appended radioiodinated peptides containing D-amino acids.
Bioconjugate chemistry 1999;10(2):231-40.
-
1998: Govindan S V; Shih L B; Goldenberg D M; Sharkey R M; Karacay H; Donnelly J E; Losman M J; Hansen H J; Griffiths G L
90Yttrium-labeled complementarity-determining-region-grafted monoclonal antibodies for radioimmunotherapy: radiolabeling and animal biodistribution studies.
Bioconjugate chemistry 1998;9(6):773-82.
-
1998: Karacay H; Ong G L; Hansen H J; Griffiths G L; Goldenberg D M; Mattes M J
Intracellular processing of 99Tcm-antibody conjugates.
Nuclear medicine communications 1998;19(10):971-9.
-
1997: Sharkey R M; Karacay H; Griffiths G L; Behr T M; Blumenthal R D; Mattes M J; Hansen H J; Goldenberg D M
Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Studies in a human colon cancer xenograft model.
Bioconjugate chemistry 1997;8(4):595-604.
-
1997: Karacay H; Sharkey R M; Govindan S V; McBride W J; Goldenberg D M; Hansen H J; Griffiths G L
Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Reagent development.
Bioconjugate chemistry 1997;8(4):585-94.
-
1995: Leung S O; Karacay H; Losman M J; Griffiths G L; Goldenberg D M; Hansen H J
Bacterial expression of a kemptide fusion protein facilitates 32P labeling of a humanized, anti-carcinoembryonic antigen (hMN-14) antibody fragment.
Cancer research 1995;55(23 Suppl):5968s-5972s.
Sign-in to see more
